![Malcolm C. Kendall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malcolm C. Kendall
Directeur Général chez
Microbiome Insights, Inc.
Profil
Malcolm C.
Kendall is the founder of Microbiome Insights, Inc., founded in 2015, and holds the title of Chief Executive Officer.
Mr. Kendall is also the founder of Indel Therapeutics, Inc. Mr. Kendall was Director at Inimex Pharmaceuticals, Inc. Mr. Kendall was Director at Twinstrand Therapeutics, Inc. Mr. Kendall was Vice President at Lumira Capital Investment Management, Inc. Mr. Kendall completed undergraduate studies at Washington & Lee University.
Mr. Kendall earned an MBA from The University of North Carolina at Charlotte.
Postes actifs de Malcolm C. Kendall
| Sociétés | Poste | Début |
|---|---|---|
Microbiome Insights, Inc.
 Microbiome Insights, Inc. BiotechnologyHealth Technology Provides microbiome sequencing and bioinformatic analysis for pharma, biotech, nutrition, cosmetic & agriculture clients | Directeur Général | 01/01/2015 |
Anciens postes connus de Malcolm C. Kendall
| Sociétés | Poste | Fin |
|---|---|---|
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Directeur Général | - |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biological drugs | Directeur/Membre du Conseil | - |
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes innate defense regulators | Directeur/Membre du Conseil | - |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Corporate Officer/Principal | - |
Formation de Malcolm C. Kendall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes innate defense regulators | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Washington & Lee University
 Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biological drugs | Health Technology |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microbiome Insights, Inc.
Microbiome Insights, Inc. BiotechnologyHealth Technology Provides microbiome sequencing and bioinformatic analysis for pharma, biotech, nutrition, cosmetic & agriculture clients | Health Technology |
Choisissez Zonebourse 
